Document is current
Any future updates will be listed below
-
Authors
Giacomelli, Andrea
Conti, Federico
Pezzati, Laura
Oreni, Letizia
Ridolfo, Anna Lisa
Morena, Valentina
Bonazzetti, Cecilia
Pagani, Gabriele
Formenti, Tiziana
Galli, Massimo
Rusconi, Stefano http://orcid.org/0000-0002-0375-9990
- License Information
-
More Information
Article History
Received: 22 December 2020
Accepted: 8 June 2021
First Online: 22 June 2021
Declarations
:
: The study protocol was reviewed and approved by the Comitato Etico Interaziendale Milano Area 1 (Local IRB). All methods were performed in accordance with the relevant guidelines and regulations. A dedicated informed consent was obtained by all subjects.
: Not required.
: AG received consultancy fees from Mylan and non-financial educational support and research Grant from Gilead. SR received grants, fees for speaker’s bureau, advisory boards and CME activities from BMS, ViiV, MSD, Mylan, Gilead, Janssen. MG received grants, fees for speaker’s bureau, advisory boards and CME activities from BMS, ViiV, MSD, AbbVie, Gilead, Janssen and Roche. LO, LP, FC, VM, CB, GP and ALR has nothing to declare.
